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Abstract 
The fitness of somatic cells of metazoan, the ability of proliferation and survival, 
depends on microenvironment. In somatic evolution, a mutated cell in a tissue 
clonally expands abnormally because of its high fitness as normal cells in a 
corresponding microenvironment. In this study, we propose the cancer cell 
hypothesis that cancer cells are the mutated cells with two characteristics: clonal 
expansion and damaging the microenvironment through the behaviours such as 
producing more poison in metabolism than normal cells. This model provides an 
explanation for the nature of invasion and metastasis, which are still controversial. In 
addition, we theoretically reasoned out that normal cells have almost the highest 
fitness in healthy microenvironments as a result of long-term organic evolution. This 
inspires a new kind of therapy of cancer, which improving microenvironment to 
make cancer cells lower in fitness than normal cells and then halt the growth of 
tumours. This general therapy relies on a mechanism differing from chemotherapy 
and targeted therapy. 
Keywords: multi-step tumourigenesis, evolution, fitness, metastasis, 
microenvironment, cancer therapy 
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Multi-step process of tumourigenesis 
Cancer is an abnormal proliferation of somatic cells caused by accumulating 
mutations in genes which control cell growth and differentiation (Bertram, 2000; 
Olopade & Pichert, 2001; Vickers, 2007). It is widely accepted today that 
tumourigenesis is a multi-step process involving about 4 ~ 6 alterations in DNA of 
somatic cells (Armitage & Doll, 1954; Cook et al, 1969; Nordling, 1953; Weinberg, 
2007). The multi-step model is effective in explaining the age-related incidence of 
cancer, the late onset of most cancer (Knudson, 2001; Weinberg, 2007) and that the 
formation of tumours requires an extended period of repeated exposure to carcinogens 
(Peto, 2001). A typical example according with multi-step model is colon carcinoma 
progresses in multi steps as (i) loss APC leads to hyperplastic epithelium, (ii) DNA 
hypomethylation leads to early adenomas, (iii) activation of K-ras leads to 
intermediate adenomas, (iv) loss of 18q TSG leads to late adenomas, loss of P53 leads 
to carcinoma and (v) invasion & metastasis (Vogelstein et al, 1988; Vogelstein et al, 
1989; Weinberg, 2007). In addition, the multi-step model is verified in breast cancer, 
and chronic myelogenous and acute lymphoblastic leukaemia (Karakosta et al, 2005). 
The multi-step tumourigenesis follows Darwinian evolution, in which individual 
cells compete with one another rather than individual organisms compete with one 
another (Weinberg, 2007). Each stage in this process involves two events (Fig. 1). The 
first event is that one cell amid a large cell population sustains a specific mutation. 
The second event is that the mutated cell clonally expands a large number. A special 
mutation confers on the mutated cell a proliferation and survival advantage compared 
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with those cells lacking this mutation (Weinberg, 2007). Mutagens as ionized 
radiation cause directly the mutation of cells. Differing from mutagens, must 
carcinogens as smoking, aflatoxin and asbestos may promote the abnormal 
proliferation of mutated cell by influencing microenvironment (Fig. 1). Mutation and 
proliferation are two indispensible and different phases of tumourigenesis in which a 
normal cell gradually transforms into a cancer cell. 
Stephen Paget proposed “seed and soil” hypothesis based on the specificity of 
target tissue for tumour metastasis more than a century ago (Ribatti et al, 2006). In 
this hypothesis, the formation of metastasis depends on the properties of the tumour 
cells as well as the permissive role of the environment (Lorusso & Rüegg, 2008). 
Tumour-associated microenvironment consists of cells, soluble factors, signalling 
molecules, extra cellular matrix and mechanical cues (Bissell et al, 2002; Hanahan & 
Weinberg, 2000; Swartz et al, 2012). As an evolutional process, the clonal expansion 
of a cell depends on not only the advantage of mutant genotype but also 
microenvironment (Fig. 1). Many researches demonstrated that microenvironment is 
closely relevant with tumour progression, as invasion and metastasis. However, 
researches on microenvironment have not provided effective targeted points for 
cancer treatment up to now. In this study, we present the cancer cell hypothesis (CCH) 
based on the progression of tumour in microenvironment and suggest a general 
therapy by comparing organic and somatic evolutions. 
Organic and somatic evolution 
Cell microenvironment 
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The fitness of somatic cells of metazoan, the ability of proliferation and survival, 
relies on cell microenvironment besides its own adaptability decided by DNA. Cell 
microenvironment, as a more general concept than tumour microenvironment, 
consists of the substances and factors around the cell. Because of the complexity and 
variability of these substances and factors, it is difficult to study the effect of 
microenvironment on cell evolution. For simplification, we divide all substances and 
factors of cell microenvironment into two types as nutriment and poison. Nutriments 
are substances and factors favourable to the survival of cells, as glucose, oxygen and 
various necessary factors. Poisons are substances and factors harmful to the survival 
of cells, as toxic metabolites, exogenous toxins and inhibiting factors. 
Normal cells completing the normal physiological function of organs have the 
same DNA as initial germ cell or harbour some additional neutral mutations which do 
not influence the fitness. A microenvironment can be evaluated by the survival 
conditions of normal cells. In this study, we indicate the level of microenvironment 
with Environment Index (EI) which ranges at 0 ~ 1. EI = 1 means the best 
microenvironment where normal cells have the highest fitness. EI = 0 means the 
worst microenvironment where normal cells die. EI is decided by the concentrations 
of nutriments and poisons in microenvironment. A healthy microenvironment (EI 
close to 1) needs the coordination of all substances and factors, i.e. each nutriment or 
poison reaches to the optimal concentration. Each of factors is enough to destroy a 
microenvironment so the polymorphism of microenvironment increases with the 
decrease of EI. Improving a high EI microenvironment is difficult comparing with 
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destroying it.  
In the light of the survival status of normal cells, we qualitatively divide the 
microenvironment into three areas as healthy, diseased and moribund respectively 
(Fig. 2). In general, the microenvironments decide the fitness of normal cells and the 
fitness of normal cells decide the health of an individual organism. Therefore, healthy 
microenvironment means an individual is healthy and an ill individual means the 
diseased microenvironment. The EI of a microenvironment relies on two factors, local 
factor, i.e. the interaction between cells and systemic factor, i.e. the efficiency of 
organs and circulatory systems to transport and process nutriments and poisons 
effectively. 
Organic evolution 
According to Darwinian Theory, organic evolution is obedient to the rule of 
natural selection in which individuals adapting to the environment are more likely to 
pass down their genes. Natural selection retains healthy individuals and eliminates 
diseased individuals until the childbearing age (young individual), but regardless of 
whether they are healthy in old age (old individual). Therefore, natural selection 
improves the health degree of young age rather than agedness for individuals of a 
species with the evolution of DNA of the germ cell.  
The fitness of normal cells of an organism is decided by two factors, their own 
vitality and the level of microenvironment which relies on the function of organs and 
circulatory systems and the local interaction of cells. Normal cells are derived from 
the germ cell and all organs and circulatory systems are also developed from the germ 
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cell, so both factors depend on the DNA of germ cell. Therefore, the organic evolution, 
i.e. the evolution of DNA of the germ cell, brings about improvement of both factors. 
The causal chain in organic evolution is: the mutations of DNA of the germ cell → 
the variations of microenvironment and vitality of normal cells → the changes of 
fitness of normal cells → selection on healthier individuals.  
In a long-term organic evolution, normal cells of individuals increases gradually 
the fitness in healthy microenvironment, but needs not to increase the fitness in 
unhealthy microenvironment because corresponding unhealthy young individuals are 
eliminated by natural selection and old individuals are out of the effect of natural 
selection (Fig. 2). Normal cells in healthiest microenvironment are close to the 
maximal fitness because organic evolution has worked for a long time since the 
generation of metazoan hundreds of millions of years ago. Figure 2 shows 
qualitatively the change in fitness for normal cell of organisms after a long-term 
organic evolution. 
Somatic evolution 
Compared with organic evolution, i.e. the evolution of germ cell for hundreds of 
thousands to billions of years, somatic cells are also obedient to Darwinian evolution 
which lasts only a lifetime of an organism and the mutations within somatic cell 
cannot be passed down to progenies (Podlaha et al, 2012). Normal cells may be 
proliferative or dormant according to the local microenvironment relying on the 
location and the developmental stage of an individual. More mutated cells have lower 
fitness than normal cells (mutated cell 2 in Fig. 3A) based on the fact that most 
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mutations in mitosis are harmful (Eyre-Walker & Keightley, 2007). However, few 
particular cells, which are sometimes higher in fitness than normal cells, may appear 
after a large body of mutations. A mutated cell with high fitness may proliferate 
beyond the procedure of normal development. However, such a cell exceeding normal 
cells in fitness only appears when microenvironment is unhealthy as diseased 
(mutated cell 1 in Fig. 3) because normal cells almost have the highest fitness in 
healthy microenvironments as a result of organic evolution. Thus, there must be a 
critical point for a mutated cell (point C in Fig. 3A), which divides the 
microenvironment into two areas. In low EI microenvironment (the left area of point 
C in Fig. 3A), the mutated cell is higher in fitness than normal cells. In high EI 
microenvironment (the right area of point C in Fig. 3A), the mutated cell is lower in 
fitness than normal cells. 
Proliferation rate of mutated cell 
The proliferation rate of normal cells, which complies with the normal 
development procedure of an organism, can be used as a benchmark for the 
proliferation of mutated cell. With this benchmark, the proliferation rate of a mutated 
cell depends entirely on whether it exceeds normal cells in fitness. Therefore, a 
mutated cell may proliferate faster to form a hyperplasia only when it is locally higher 
in fitness than normal cells (the colour region in Fig. 3B). The proliferation rate of the 
mutated cell decreases if the microenvironment is improved to the critical point 
(region E1 in Fig. 3B) or deteriorates to moribund (region E3 in Fig. 3B). The 
unhealthy microenvironment (colour region in Fig. 3B) is the risk condition of tumour 
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progression for an organism, through comparing cellular variations in organic 
evolution and somatic evolution. Many researches on somatic evolution show the 
evolutionary nature of cancer, in which mutations confer on cancer cells to proliferate 
out of control (Forbes et al, 2008; Podlaha et al, 2012). However, the long-term 
influence of organic evolution on the fitness of in vivo cells is also important for 
understanding cancer. 
Cancer cell hypothesis 
A mutated cell may proliferate to form a tumour in special microenvironment 
according to organic and somatic evolutions. This mechanism of cell evolution can 
account for why abnormal and normal cells coexist in an organism. However, cell 
evolution process does not show why some mutated cells proliferate to benign 
tumours and others proliferate to malignant tumours featured by invasion and 
metastasis. What causes the malignance of tumour? 
“Virtuous cell” and “vicious cell” 
Cell evolution depends on microenvironment according to natural selection and 
cells affect microenvironment in turn. Different cells, which harbour different 
mutations, may be beneficial or harmful to microenvironment. Thus, we divide cells 
into two types: “vicious cell” which is harmful to microenvironment and “virtuous 
cell” which is beneficial to microenvironment. The harm of vicious cells to 
microenvironment may be derived from some behaviours, such as they produce more 
metabolic wastes or factors to inhibit other cells. The benefit of virtuous cells for 
microenvironment may be derived from other behaviours, such as they remove poison 
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or produce more beneficial factors. Obviously, vicious cells are harmful to each other 
and virtuous cells are favourable to each other. 
Virtuous cells are advantageous if closing to each other because they are 
favourable to each other. A microenvironment, in which the same virtuous cells get 
together and isolate from other cells, is more beneficial for cell survival. Therefore, 
autonomous systems, featured as clustered and autocephalous group of the same 
virtuous cells and isolate from other cells, are advantageous in somatic evolution. 
Virtuous cells in an autonomous system are high in fitness, so the individual is healthy. 
Thus, autonomous systems of virtuous cells are also advantageous in organic 
evolution. All organs of metazoans can be considered as autonomous systems formed 
in long-term organic evolution. 
The microenvironment of a specific location is only friendly to specific cells but 
hostile to other cells. Cells will not survive in an inappropriate microenvironment due 
to lack in necessary cell autonomous survival signals (Morrison & Spradling, 2008). 
The mechanism of anoikis has been considered to prevent normal cells from leaving 
their original environment and seeding at inappropriate locations (Chiarugi & 
Giannoni, 2008). Relevant researches suggest also that most kinds of normal cells are 
virtuous cells, because only virtuous cell is advantageous in both somatic and organic 
evolutions. 
Vicious cells, if they flock together, are disadvantageous because they are 
harmful to each other. A microenvironment, in which the same vicious cells get 
together and isolate from other cells, is disadvantageous for cell survival. The nature 
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of vicious cells decides them to tend to expand dispersedly which is contrary to the 
behaviours of virtuous cells. Therefore, vicious cell is featured as that easy to leave 
the original location as the result of somatic evolution. 
Cancer cell hypothesis 
Normal cells, consisting of many types of cells, are all derived from the original 
germ cell. In long-term organic evolution, each type of normal cells, which stay at a 
special location and complete corresponding physiological function, improve 
gradually their fitness in special microenvironment and help the individual organism 
to adapt increasingly to environment. A mutated cell is unlikely higher in fitness than 
local normal cells if the microenvironment is healthy (Fig. 3A). However, a mutated 
cell may proliferate faster, i.e. obtains a higher fitness, than normal cells to form a 
tumour if the microenvironment becomes diseased. A “virtuous” mutated cell with a 
high fitness as normal cells will develop a benign tumour according to its features. In 
contrast, a “vicious” mutated cell with a high fitness as normal cells will proliferate to 
a malignant tumour, featured by invasion and metastasis, because these cells are 
harmful to each other and other adjacent cells. Therefore, we assume the cancer cell 
hypothesis (CCH) that cancer cell is a mutated cell which is higher in fitness than 
normal cells in a diseased microenvironment and is harmful to each other and other 
adjacent cells (destroying microenvironment) by some behaviours, such as producing 
more poison in metabolism than normal cells. 
Metastatic progression of tumour 
Multistage growth of tumour 
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Researches have shown that the vast majority of tumours are monoclonal 
growths descended from single progenitor cells (Thompson et al, 1996; Weinberg, 
2007). By theoretical analysis, two conditions determine the progression of a tumour: 
a mutated cell with higher fitness than normal cells and a given microenvironment 
where the EI is below the critical point for the mutated cell (seed and soil).  
In the early phase, when a tumour is small and invisible, the surrounding 
microenvironment is mainly decided by ambient substances and factors obeying the 
rule of diffusion. Although they damage microenvironment according to CCH, cancer 
cells influence the microenvironment little because of too few in number. Therefore, 
the growth rates for tumours in the early phase are indeterminate because of the 
diversiform ambient conditions, although the tumour is difficult to be observed due to 
the small size (Fig. 4). 
In the middle phase, a tumour gradually grows up and becomes visible. The 
effect destroying the microenvironment for cancer cells exceeds the role of ambient 
conditions when the tumour grows beyond a certain volume. As a result, the diseased 
microenvironment which is necessary for the tumour to grow (Fig. 3) can self-sustain 
by enough cancer cells and ambient conditions provides only a secondary influence 
on microenvironment. Thus, the level of microenvironment depends mainly on the 
volume of tumour. This correlation between microenvironment and tumour volume 
answered why the same kind of tumours in the middle phase grow in similar rate 
(middle phase in Fig. 4). For example, radiographic studies on human cancer growth 
rates which are evaluated by the tumour volume doubling time (TVDT) show no big 
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difference between primary tumours and matched metastases or between metastases at 
different sites (Friberg & Mattson, 1997). Therefore, cancer growth rates at the 
detectable stage are considered as an inherent property reflecting the provenance of 
the cancers (Klein, 2009; Kusama et al, 1972). 
 Growth rates can plateau as tumours become large (Finlay et al, 1988), where 
proliferation slows. This deceleration depending on that a large tumour results in 
nutrient restrictions or poison excess, means a microenvironment close to moribund 
(Fig. 3 area E3), so cancer cells reduce increasingly the fitness. Blood circulation 
improves the microenvironment once new blood vessels grow inside a tumour. A 
tumour with new vessels grows again to break through the bottleneck. A large enough 
tumour, regardless of primary or metastatic, will damage the whole microenvironment 
of a patient by transferring poison to the whole body or expending excessive nutrient 
through blood circulation. Figure 4 shows the different growth rates for a tumour in 
early, middle and late phases. 
Metastasis 
Invasion and metastasis indicator the malignance of a tumour and cause the death 
of most patients (Hanahan & Weinberg, 2011; Weinberg, 2007). Understanding the 
mechanism of metastasis is significant for treatment of terminal cancers. Cancer 
metastasis involves behaviours of malignant cells as separation, movement, stay, 
survival and proliferation. These behaviours are assumed based on various molecular 
mechanisms. For example, epithelial-mesenchymal transition is considered as a 
possible means by which transformed epithelial cells can acquire the abilities to 
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invade and disseminate (Klymkowsky & Savagner, 2009; Polyak & Weinberg, 2009; 
Thiery et al, 2009; Yilmaz & Christofori, 2009). In addition, invasion and metastasis 
of cancer are relevant with the microenvironment around the tumour involving 
stromal cells and macrophages (Joyce & Pollard, 2009; Kalluri & Zeisberg, 2006; 
Kessenbrock et al, 2010; Qian & Pollard, 2010). However, the basic mechanism of 
metastasis is still dubious so far. 
According to CCH, cancer cells as “vicious cell” are harmful to not only adjacent 
normal cells but also other cancer cells. Malignant tumours are loose instead of 
compact structures because of the nature of “vicious cell”. Therefore, cancer cells are 
lower in adhesion and easier to be separated from a tumour as a result of evolution. In 
addition, whether cancer cells can move a long distance to the targeted tissue and 
surviving to proliferate relies on two conditions: the whole body microenvironment 
increasingly deteriorates and more cancer cells are separated from the primary tumour 
with the growth of tumour. Obviously, the probability of metastasis increases with the 
progression of a tumour. 
This theoretical result accords with the linear progression model of metastasis in 
which metastasis is correlative with tumour volume. Contrary to the linear 
progression model, the parallel progression model of metastasis persists that 
metastases must be initiated long before the first symptoms appeared or the primary 
tumour was diagnosed and proliferate in parallel with carcinoma in situ (Collins et al, 
1956; Friberg & Mattson, 1997). Because of the similar growth rates based on no big 
different TVDTs, metastases were simply too large to be accounted for by initiation at 
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a late stage of primary tumour development (Klein, 2009). However, the growth rates 
for tumours in the early phase, which are different from the relatively stable growth 
rates for tumours in the middle phase, are indeterminate because of the diversiform 
microenvironment (Fig. 4). Metastases initiated at the late phase of a primary tumour 
might develop faster because of the diseased microenvironment. Therefore, the 
parallel progression model is difficult to replace the linear progression model. 
Inspiration for treatment 
Many therapeutic methods of cancer have applied in the clinic today. Physical 
therapies as surgical operation and radiation therapy are suited only to treat 
preinvasive carcinomas but are helpless for metastatic carcinomas. Chemotherapy and 
targeted therapy are the treatment approaches for cancers in each stage. 
Chemotherapy. Chemotherapy as a common therapy for cancers has come into 
use since the last century (DeVita & Chu, 2008). Various chemotherapy drugs, as 
antimetabolites, mitotic inhibitors and anti-tumour antibiotics, are widely used to treat 
cancers. Chemotherapy kills cancer cells by aiming at their general characteristics as 
rapid division. However, chemotherapy drugs are also toxic to normal cells and 
harmful to the whole microenvironment of patients (red arrow in Fig. 5). The risk for 
patients lies in that if chemotherapy cannot kill every cancer cell those residual ones 
will proliferate and metastasize faster because chemotherapy drugs caused the 
deterioration of microenvironment. Many cases confirmed that a recrudescent cancer 
after chemotherapy progresses faster. 
Targeted therapy. Targeted therapy was started in clinical application a dozen 
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years ago. Targeted drugs, designed by the technology of molecule biology, aim at the 
specific antigens found on the cell surface (monoclonal antibodies) or the target 
proteins inside a cell (small molecules). For example, imatinib mesylate, as a tyrosine 
kinase inhibitor targeting abnormal proteins or enzymes that form inside cancer cells 
and promote uncontrolled growth, is used to treat gastrointestinal stromal tumour and 
chronic myeloid leukaemia (Druker et al, 2006; Talpaz et al, 2002). Targeted therapy 
restrains the proliferation of cancer cells but has no or only little side effect on normal 
cells (blue arrow in Fig. 5). It is considered that personalized targeted therapy may be 
the promising therapy in the future. However, targeted therapy faces at least two 
challenges in treatment of cancer which is the collection of more than 100 diseases 
(Weinberg, 2007). First, diverse mutations and polymorphic microenvironments lead 
to heterogeneous cancer cells (Meacham & Morrison, 2013). Current targeted drugs 
are effective for only limited types of cancer and targeted drugs for most cancers will 
be still absent in the near future, because it is difficult and expensive to find effective 
targeted points of cancers and invent corresponding drugs. Second, capricious cancer 
cells often generate a resistance to drugs so the curative effect of targeted drugs 
declines soon for most patients. 
Inspiration for new therapy. From cell evolution model discussed in this study, 
cancer cells cannot abnormally proliferate in a microenvironment superior to the 
critical point (Fig. 3). Diseased microenvironment is the precondition for tumour 
progression. If the microenvironment is superior to the critical point, a tumour in the 
early phase may stop to grow so cancer is controlled (green arrow in Fig. 5). Although 
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tumours in the early phase are difficult to be found, improving microenvironment may 
prevent potential cancers. 
For grown tumours in middle and late phases, improving microenvironment can 
increase the fitness of normal cells to resist the harm of cancer cells. Metastases from 
a tumour in situ cannot stay or proliferate if the microenvironment of targeted location 
is superior to the critical point. Therefore, improving microenvironments of the whole 
body can prevent the invasion and metastasis of tumours in some extent. As if this 
approach is suited to each phase of cancer, however, improving microenvironment 
does not necessarily come true for a grown tumour because the deterioration of 
microenvironment caused by cancer cells is not easy to be halted. If that is the case, 
the key to cure cancer is how to overcome the harm of cancer cells to improve 
microenvironment. 
Some terminal cancer patients self-cured without any treatment. Although such 
cases happen with only a very small proportion of patients, they are very common 
among so many patients around the world. What killed cancer cells which often 
escape from the severe hunting down of chemotherapy, radiotherapy and other 
therapies? That is difficult to be explained by present cancer knowledge. The 
improvement of microenvironment, which may be caused by the changes in diet, 
sports and emotion, seems a bit reasonable although direct evidences are absent yet. 
Discussions 
Cancer is essentially the result of somatic evolution throughout the lifetime of an 
organism (Breivik, 2005; Greaves & Maley, 2012; Podlaha et al, 2012). Proliferating 
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faster than normal cells means cancer cells are higher in fitness. As a result of organic 
evolution, normal cells are continuously improved their fitness so they achieve almost 
the highest fitness in healthy microenvironment today. Therefore, cancer cells, as a 
mutant of normal cell, are higher in fitness than normal cells in only unhealthy 
microenvironments. Based on cell evolution, we proposed the hypothesis CCH which 
cancer cells are advantageous in a diseased microenvironment and can spontaneously 
destroy microenvironment. CCH shows why some tumours are malignant and others 
are benignant. 
Summarizing this study, cancer progression generally needs three conditions: a 
series of specific mutations result in cancer cells which are higher in fitness than 
normal cells, microenvironment becomes diseased and “vicious” cancer cells can 
maintain a diseased microenvironment favourable to self-expansion. Although this 
statement does not show a specific mechanism in molecular level, which is often 
required by current cancer biology, it provides a more general and logic conclusion 
for most cancers. We are convinced of that deterioration of microenvironment plays 
key roles in initiating a cancer, which is not inferior to the onset of a cancer cell. 
Maybe, we cannot consider a cancer in the early phase as a cancer because a cancer 
cell will not develop to a tumour if the microenvironment does not deteriorate. In a 
way, sickness leads to cancer rather than cancer leads to sickness. “seed” and “soil” 
are equally important in tumourigenesis. 
Current researches of cancer treatment mainly focus on killing or restraining 
cancer cells. This study may inspire researchers of cancer to find drugs saving normal 
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cells instead of killing or restraining cancer cells. This kind of therapy is different in 
mechanism from chemotherapy and targeted therapy (Fig. 5). It may be advantageous 
in three aspects compared with existing therapies. First, it applies to all types of 
cancer because therapy aims at the general characteristics of all mutated cells. Second, 
there is no side effect as chemotherapy because therapy is not harmful but favourable 
to normal cells. Third, cancer cannot produce resistance to drugs because therapy does 
not increase the selection pressure for cancer cells. Meanwhile, this kind of therapy 
will face with some challenges. First, improving microenvironment is not easy to 
come true in the face of the destruction of cancer cells. Second, to develop new 
therapies based on the theoretical inference of improving microenvironment needs a 
great deal of deep researches in clinic. Obviously, to evaluate a healthy 
microenvironment must be simpler than to identify various cancer cells. 
In existing therapies, drugs play the role battling with cancer cells. In therapies 
of improving microenvironment, normal cells next to tumour are the leading roles 
combating with cancer cells and treatment only provides an ancillary support. That 
accords with the philosophy of traditional Chinese medicine, in which treatment lies 
in assisting the self-healing ability of an organism to get rid of diseases. All doctors 
would advise people to change life style, involving diet, sports and emotion, to 
prevent cancer. Maybe, changing life style may be a main treatment method for a 
cancer patient. 
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Fig. 1. Multi-step process of tumourgenesis. Each stage in this process involves two events: one cell 
amid a large cell population sustains a specific mutation and the mutated cell clonally expands. Mutagens 
are the carcinogenic factors causing the mutation of cell (mut1~mutn) and carcinogens are carcinogenic 
factors promoting clonal expansion of mutated cell through changing microenvironment. 
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Fig. 2. The fitness of normal cell in organic evolution. The in vivo microenvironment is qualitatively 
divided into three levels as healthy, diseased and moribund, respectively. The fitness of normal cells 
decides the fitness of an individual. Long-term organic evolution caused normal cells to have almost the 
highest fitness in healthy microenvironment. Arrows in the figure indicate the evolution of normal cells 
which have the same DNA as germ cell. 
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Fig. 3. Mutated somatic cells. Most mutated cells (mutated cell 2) have the fitness below that of normal 
cells. Few mutated cells (mutated cell 1) have the fitness above normal cells when microenvironment is 
worse than the critical point (point C). Almost all mutated cells have the fitness below normal cells in a 
healthy microenvironment because normal cells have almost the highest fitness according to organic 
evolution. Mutated cell 1 may proliferate abnormally, only if it has a high fitness as normal cells. The 
tumour growth rate increases with the deterioration of microenvironment next to the critical point (area 
E1). The tumour growth rate decreases with the further deterioration of microenvironment (area E3) 
because the microenvironment closing to moribund reduces the vitality of all cells. Therefore, a tumour 
grows with maximum rate in area E2.  
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Fig. 4. Three phases of tumour progression. A tumour in the early phase depends entirely on ambient 
conditions because too few cancer cells cannot influence microenvironment. A tumour in the middle 
phase grows in a relatively fixed rate because the microenvironment is mainly relevant with tumour 
volume. A tumour in the late phase grows slow down because a large tumour causes microenvironment 
close to moribund. Thereafter, newborn blood vessels improve the microenvironment and accelerate 
tumour growth again. 
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Fig. 5. Therapies. Chemotherapy destroys microenvironment to kill cancer cells so it damages normal 
cells also. Targeted therapy reduces the fitness of cancer cells by attacking the special targeted point, to 
halt the progression of a tumour. Targeted therapy has no or only little side effect for normal cells, but 
cancer cells will generate resistances to targeted drugs. New therapy makes cancer cells lower in fitness 
than normal cells by improving microenvironment. 
 
